Inhibitor Therapeutics (INTI) Market Capitalization (2013 - 2026)
Inhibitor Therapeutics' Market Capitalization was $13.9 million in Q2 2026, up 101.4% from $6.9 million a year earlier but down 26.8% from the prior quarter.
Powered by 
Analysis
Inhibitor Therapeutics (INTI) Market Capitalization (2013 - 2026) Analysis & Trends
For FY2025, Market Capitalization at Inhibitor Therapeutics came in at $8.63 million, down 16.5% from FY2024.
- Market Capitalization has now declined for four consecutive years, with a five-year compound annual growth rate of -10.4% (FY2020 to FY2025).
- In earlier years, Market Capitalization was $10.34 million in FY2024 (-33.2%), $15.48 million in FY2023 (-57.7%), $36.62 million in FY2022 (-35.2%) and $56.53 million in FY2021 (+278.2%).
- Quarterly Market Capitalization has moved between $6.88 million (Q2 2023) and $56.53 million (Q4 2021) over five years.
- Compared with a year earlier, Market Capitalization was higher in three of the last eight quarters, with growth averaging 16.2%.
- The best year-over-year quarter for Market Capitalization over five years was Q4 2021 (growth of 278.2%); the worst was Q2 2023 (a decline of 81.7%).
- Per Business Quant data, INTI's Market Capitalization in the three quarters before Q2 2026 was $18.98 million (Q1 2026), $8.63 million (Q4 2025) and $8.63 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn |
| 10 | Inhibitor Therapeutics | 13.90 Mn | 6.72 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 13.90 Mn |
| Mar 31, 2026 | 18.98 Mn |
| Dec 31, 2025 | 8.63 Mn |
| Sep 30, 2025 | 8.63 Mn |
| Jun 30, 2025 | 6.90 Mn |
| Mar 31, 2025 | 8.62 Mn |
| Dec 31, 2024 | 10.34 Mn |
| Sep 30, 2024 | 15.51 Mn |
| Jun 30, 2024 | 13.79 Mn |
| Mar 31, 2024 | 12.06 Mn |
| Dec 31, 2023 | 15.48 Mn |
| Sep 30, 2023 | 8.60 Mn |
| Jun 30, 2023 | 6.88 Mn |
| Mar 31, 2023 | 10.31 Mn |
| Dec 31, 2022 | 36.62 Mn |
| Sep 30, 2022 | 18.84 Mn |
| Jun 30, 2022 | 37.69 Mn |
| Mar 31, 2022 | 48.99 Mn |
| Dec 31, 2021 | 56.53 Mn |
| Sep 30, 2021 | 56.38 Mn |
API Access
Inhibitor Therapeutics Market Capitalization API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=market-capitalization&ticker=INTI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "market-capitalization", "ticker": "INTI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=market-capitalization&ticker=INTI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();